OX-23 hybridoma cell line
SIGMA/00010402 - Anti- Factor H, human
Product Type: Chemical
| biological source | Mouse x Mouse Hybridoma |
| ImmunoDon | BALB/c mouse spleen |
| isotype | IgG1 |
| Myeloma | NS0 |
| packaging | pkg of vial of cells 00010402-1VL |
| tube of 5 μg 00010402-DNA-5UG | |
| Quality Level | 100 ![]() |
| Reactivity | Anti-Factor H, human |
| technique(s) | cell culture | mammalian: suitable |
| Biochem/physiol Actions: | Mouse x Mouse hybridoma |
| Biochem/physiol Actions: | The hybridoma line OX-23 was raised by immunizing BALB/c mice with Factor H and fusion of spleen cells with NS0 mouse myeloma cells. The antibody was shown to detect human complement control protein, Factor H. OX-23, also known as MRC OX-23, reduced the increase in cofactor activity observed in the presence of OX-24 (Sigma Catalogue no. 00010403). It was reported that OX-23 and OX-24 react with different epitopes on the Factor H molecule. |
| Disclaimer: | This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form. |
| Immunogen: | Human Factor H |
| Other Notes: | Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information. |
| Packaging: | NOTE: Both the cell line and DNA from the cell line may be available for this product. Please choose -1VL or VIAL for cells, or -DNA-5UG for DNA. |
| Preparation Note: | RPMI 1640 (R0883) + 2mM Glutamine (G7513) + 10% FBS / FCS (F2442) ![]() |
| Preparation Note: | Maintain cultures between 3-9 x 100,000 cells/ml; 5% CO2; 37°C. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41106514 |

